Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

The effect of weekly iron and vitamin A supplementation on hemoglobin levels and iron status in adolescent schoolgirls in western Kenya.

Leenstra T, Kariuki SK, Kurtis JD, Oloo AJ, Kager PA, ter Kuile FO.

Eur J Clin Nutr. 2009 Feb;63(2):173-82. Epub 2007 Oct 10.

PMID:
17928808
2.

Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.

Obonyo CO, Taylor W, Ekvall H, Kaneko A, Ter Kuile F, Olliaro P, Bjorkman A, Oloo AJ.

Ann Trop Med Parasitol. 2007 Jun;101(4):281-95.

PMID:
17524243
3.

Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.

Obonyo CO, Ochieng F, Taylor WR, Ochola SA, Mugitu K, Olliaro P, ter Kuile F, Oloo AJ.

Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):585-91.

PMID:
15307433
4.

Prevalence and severity of malnutrition and age at menarche; cross-sectional studies in adolescent schoolgirls in western Kenya.

Leenstra T, Petersen LT, Kariuki SK, Oloo AJ, Kager PA, ter Kuile FO.

Eur J Clin Nutr. 2005 Jan;59(1):41-8.

PMID:
15305179
5.

Prevalence and severity of anemia and iron deficiency: cross-sectional studies in adolescent schoolgirls in western Kenya.

Leenstra T, Kariuki SK, Kurtis JD, Oloo AJ, Kager PA, ter Kuile FO.

Eur J Clin Nutr. 2004 Apr;58(4):681-91.

PMID:
15042138
6.

Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing.

Terlouw DJ, Nahlen BL, Courval JM, Kariuki SK, Rosenberg OS, Oloo AJ, Kolczak MS, Hawley WA, Lal AA, Kuile FO.

Antimicrob Agents Chemother. 2003 Sep;47(9):2929-32.

7.

Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya.

Leenstra T, ter Kuile FO, Kariuki SK, Nixon CP, Oloo AJ, Kager PA, Kurtis JD.

J Infect Dis. 2003 Jul 15;188(2):297-304. Epub 2003 Jul 1.

PMID:
12854087
8.

Factors affecting use of permethrin-treated bed nets during a randomized controlled trial in western Kenya.

Alaii JA, Hawley WA, Kolczak MS, ter Kuile FO, Gimnig JE, Vulule JM, Odhacha A, Oloo AJ, Nahlen BL, Phillips-Howard PA.

Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):137-41.

PMID:
12749497
9.

Permethrin-treated bed nets in the prevention of malaria and anemia in adolescent schoolgirls in western Kenya.

Leenstra T, Phillips-Howard PA, Kariuki SK, Hawley WA, Alaii JA, Rosen DH, Oloo AJ, Nahlen BL, Kager PA, ter Kuile FO.

Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):86-93.

PMID:
12749490
10.

Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya.

Phillips-Howard PA, Nahlen BL, Kolczak MS, Hightower AW, ter Kuile FO, Alaii JA, Gimnig JE, Arudo J, Vulule JM, Odhacha A, Kachur SP, Schoute E, Rosen DH, Sexton JD, Oloo AJ, Hawley WA.

Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):23-9.

PMID:
12749482
11.

The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya I. Development of infrastructure and description of study site.

Phillips-Howard PA, Nahlen BL, Alaii JA, ter Kuile FO, Gimnig JE, Terlouw DJ, Kachur SP, Hightower AW, Lal AA, Schoute E, Oloo AJ, Hawley WA.

Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):3-9.

PMID:
12749479
12.

Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya.

Terlouw DJ, Courval JM, Kolczak MS, Rosenberg OS, Oloo AJ, Kager PA, Lal AA, Nahlen BL, ter Kuile FO.

J Infect Dis. 2003 Feb 1;187(3):467-76. Epub 2003 Jan 24.

PMID:
12552431
13.

Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.

Terlouw DJ, Aidoo MA, Udhayakumar V, Kolczak MS, Oloo AJ, Kager PA, Lal AA, Nahlen BL, Kuile FO.

J Infect Dis. 2002 Dec 1;186(11):1661-8. Epub 2002 Nov 5.

PMID:
12447744
14.

A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.

Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, Horton J, Brueckner R.

Clin Infect Dis. 2001 Dec 15;33(12):1968-74. Epub 2001 Nov 7.

PMID:
11700577
15.

Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII.

Udhayakumar V, Kariuki S, Kolczack M, Girma M, Roberts JM, Oloo AJ, Nahlen BL, Lal AA.

Am J Trop Med Hyg. 2001 Aug;65(2):100-7.

PMID:
11508382
16.

All-cause mortality among young children in western Kenya. VI: the Asembo Bay Cohort Project.

McElroy PD, ter Kuile FO, Hightower AW, Hawley WA, Phillips-Howard PA, Oloo AJ, Lal AA, Nahlen BL.

Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):18-27.

PMID:
11425174
17.

Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project.

McElroy PD, ter Kuile FO, Lal AA, Bloland PB, Hawley WA, Oloo AJ, Monto AS, Meshnick SR, Nahlen BL.

Am J Trop Med Hyg. 2000 Apr;62(4):504-12.

PMID:
11220768
19.

Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project.

McElroy PD, Lal AA, Hawley WA, Bloland PB, Kuile FO, Oloo AJ, Harlow SD, Lin X, Nahlen BL.

Am J Trop Med Hyg. 1999 Dec;61(6):932-40.

PMID:
10674673
20.

Maintenance and sustained use of insecticide-treated bednets and curtains three years after a controlled trial in western Kenya.

Kachur SP, Phillips-Howard PA, Odhacha AM, Ruebush TK, Oloo AJ, Nahlen BL.

Trop Med Int Health. 1999 Nov;4(11):728-35.

21.

Current and future concerns for malaria in Africa.

Oloo AJ.

East Afr Med J. 1999 Aug;76(8):419-20. Review. No abstract available.

PMID:
10520344
22.

Time to reappearance of malaria parasites following various drug treatment regimens in a holoendemic area of western Kenya.

Shanks GD, Ragama BO, Oloo AJ.

Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):304-5. No abstract available.

PMID:
10492766
23.

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children.

Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, Oloo AJ, Hawley W, Lal A, Nahlen B, Campbell CC.

Am J Trop Med Hyg. 1999 Apr;60(4):641-8.

PMID:
10348241
24.

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population.

Bloland PB, Ruebush TK, McCormick JB, Ayisi J, Boriga DA, Oloo AJ, Beach R, Hawley W, Lal A, Nahlen B, Udhayakumar V, Campbell CC.

Am J Trop Med Hyg. 1999 Apr;60(4):635-40.

PMID:
10348240
25.
26.

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW.

Am J Trop Med Hyg. 1998 Nov;59(5):813-22.

PMID:
9840604
27.

Blood transfusions for severe malaria-related anemia in Africa: a decision analysis.

Obonyo CO, Steyerberg EW, Oloo AJ, Habbema JD.

Am J Trop Med Hyg. 1998 Nov;59(5):808-12.

PMID:
9840603
28.

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.

Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott TR.

Clin Infect Dis. 1998 Sep;27(3):494-9.

PMID:
9770146
29.

Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa.

Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK.

Trop Med Int Health. 1998 Jul;3(7):543-52.

30.

A geographic information system applied to a malaria field study in western Kenya.

Hightower AW, Ombok M, Otieno R, Odhiambo R, Oloo AJ, Lal AA, Nahlen BL, Hawley WA.

Am J Trop Med Hyg. 1998 Mar;58(3):266-72.

PMID:
9546401
31.
32.

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya.

Andersen SL, Oloo AJ, Gordon DM, Ragama OB, Aleman GM, Berman JD, Tang DB, Dunne MW, Shanks GD.

Clin Infect Dis. 1998 Jan;26(1):146-50.

PMID:
9455524
33.

Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults.

Udhayakumar V, Ongecha JM, Shi YP, Aidoo M, Orago AS, Oloo AJ, Hawley WA, Nahlen BL, Hoffman SL, Weiss WR, Lal AA.

Eur J Immunol. 1997 Aug;27(8):1952-7.

PMID:
9295031
34.

Dose- and time-dependent relations between infective Anopheles inoculation and outcomes of Plasmodium falciparum parasitemia among children in western Kenya.

McElroy PD, Beier JC, Oster CN, Onyango FK, Oloo AJ, Lin X, Beadle C, Hoffman SL.

Am J Epidemiol. 1997 May 15;145(10):945-56.

PMID:
9149666
35.

Plasmodium falciparum gametocytemia in Kenyan children: associations among age, intensity of exposure to transmission, and prevalence and density of subsequent gametocytemia.

Jones TR, McElroy PD, Oster CN, Beier JC, Oloo AJ, Onyango FK, Chumo DK, Sherwood JA, Hoffman SL.

Am J Trop Med Hyg. 1997 Feb;56(2):133-6.

PMID:
9080869
36.

Assessment of potential indicators for protein-energy malnutrition in the algorithm for integrated management of childhood illness.

Bern C, Zucker JR, Perkins BA, Otieno J, Oloo AJ, Yip R.

Bull World Health Organ. 1997;75 Suppl 1:87-96.

37.

Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission.

Perkins BA, Zucker JR, Otieno J, Jafari HS, Paxton L, Redd SC, Nahlen BL, Schwartz B, Oloo AJ, Olango C, Gove S, Campbell CC.

Bull World Health Organ. 1997;75 Suppl 1:33-42.

38.

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.

Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA.

Infect Immun. 1996 Jul;64(7):2716-23.

39.

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.

Sherwood JA, Copeland RS, Taylor KA, Abok K, Oloo AJ, Were JB, Strickland GT, Gordon DM, Ballou WR, Bales JD Jr, Wirtz RA, Wittes J, Gross M, Que JU, Cryz SJ, Oster CN, Roberts CR, Sadoff JC.

Vaccine. 1996 Jun;14(8):817-27.

PMID:
8817830
40.

Field evaluation of a polymerase chain reaction-based nonisotopic liquid hybridization assay for malaria diagnosis.

Oliveira DA, Shi YP, Oloo AJ, Boriga DA, Nahlen BL, Hawley WA, Holloway BP, Lal AA.

J Infect Dis. 1996 May;173(5):1284-7.

PMID:
8627088
41.

Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria.

Lal AA, Hughes MA, Oliveira DA, Nelson C, Bloland PB, Oloo AJ, Hawley WE, Hightower AW, Nahlen BL, Udhayakumar V.

Infect Immun. 1996 Mar;64(3):1054-9.

42.

Genetic conservation of the Plasmodium falciparum apical membrane antigen-1 (AMA-1).

Oliveira DA, Udhayakumar V, Bloland P, Shi YP, Nahlen BL, Oloo AJ, Hawley WE, Lal AA.

Mol Biochem Parasitol. 1996 Feb-Mar;76(1-2):333-6. No abstract available.

PMID:
8920023
43.

Some emerging issues on the malaria problem in Kenya.

Oloo AJ, Vulule JM, Koech DK.

East Afr Med J. 1996 Jan;73(1):50-3. Review.

PMID:
8625864
44.

Efficacy of halofantrine in the treatment of uncomplicated falciparum malaria.

Mbori-Ngacha DA, Onyango FE, Chunge C, Luta M, Oloo AJ, Muga RO.

East Afr Med J. 1995 Dec;72(12):796-9.

PMID:
8689980
45.

Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design.

Beadle C, McElroy PD, Oster CN, Beier JC, Oloo AJ, Onyango FK, Chumo DK, Bales JD, Sherwood JA, Hoffman SL.

J Infect Dis. 1995 Oct;172(4):1047-54. Erratum in: J Infect Dis 1995 Nov;172(5):1424.

PMID:
7561179
46.
47.

Self-treatment of malaria in a rural area of western Kenya.

Ruebush TK, Kern MK, Campbell CC, Oloo AJ.

Bull World Health Organ. 1995;73(2):229-36.

48.

Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia.

McElroy PD, Beier JC, Oster CN, Beadle C, Sherwood JA, Oloo AJ, Hoffman SL.

Am J Trop Med Hyg. 1994 Nov;51(5):523-32.

PMID:
7985743
49.

Evaluation of the QBC method to detect malaria infections in field surveys.

Oloo AJ, Ondijo SO, Genga IO, Boriga DA, Owaga ML, Ngare D, Gathecha E.

East Afr Med J. 1994 May;71(5):297-9.

PMID:
7925060
50.

Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay.

Beadle C, Long GW, Weiss WR, McElroy PD, Maret SM, Oloo AJ, Hoffman SL.

Lancet. 1994 Mar 5;343(8897):564-8.

PMID:
7906328

Supplemental Content

Support Center